PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA...

Read More


SUBMISSION OF APPLICATIONS FOR THE CLINICAL RESEARCH PROJECTS COMPETITION IS CLOSED

Ten full applications were received in response to the Request For Proposals for the RakFond's competition of clinical research projects in oncology...

Read More


WHAT IS CLINICAL RESEARCH

RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients...

Read More


NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting...

Read More


NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting...

Read More


One week left to register applications for the competition of clinical research projects in oncology

Applications submission is open for proposals of randomized clinical trials in oncology and related areas. Application due date is July 01, 2019. Online pre-registration is required by June 20, 2019...

Read More


RUSSIAN ONCOLOGISTS PROPOSED A NEW WAY TO PREVENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

Results of the clinical trial are presented today at the largest oncology ASCO meeting in Chicago, USA...

Read More


RESULTS OF THE SUPPORTED RESEARCH ON LUNG CANCER DIAGNOSTIC PLATFORM DEVELOPMENT

В Санкт-Петербурге завершилось второе исследование, поддержанное исследовательским грантом RUSSCO и РакФонда для молодых ученых и начинающих исследователей в области онкологии... Результаты проведенного исследования будут в ближайшее время опубликованы в специализированных изданиях...

Read More


RAKFOND HAS JOINED “NUZHNA POMOSCH” PLATFORM

RakFond has successfully completed an expert assessment and became a participant on the platform "Nuzhna pomosch". From now on, donations for RakFond can be made through the platform. In addition, anyone can organize a fundraising event for RakFond at https://sluchaem.ru...

Read More


FINAL RESULTS OF THE RESEARCH SUPPORTED BY RAKFOND ARE PUBLISHED

American Society of Clinical Oncology (ASCO) released the materials of the upcoming Annual Meeting in Chicago on May 31 - June 4, 2019. The oral presentation of the final results of the randomized phase II trial, supported by RakFond, will be given by its author Dr. Alexey Rumyantsev during the Symptoms and Survivorship session...

Read More